Quantcast

Latest Curis Inc. Stories

2015-04-18 08:21:04

PHILADELPHIA, April 18, 2015 /PRNewswire/ -- Aurigene and its partner Curis, Inc.

2014-04-08 04:22:04

- Debio 0932 demonstrated anti-tumor activity and synergy with various SOC agents in in vitro and xenograft models of NSCLC and RCC - LAUSANNE, Switzerland and LEXINGTON, Mass., April

2009-08-06 08:00:00

CAMBRIDGE, Massachusetts and LAUSANNE, Switzerland, August 6 /PRNewswire/ -- Curis, Inc.

2008-10-23 09:00:38

Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing the next generation of proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the 7th Annual BIO Investor Forum Conference, at 3:45 p.m. local time (6:45 p.m.

2008-10-21 09:00:53

Curis, Inc. (NASDAQ:CRIS), a drug development company focused on developing proprietary targeted medicines primarily for cancer treatment, today announced that the Company will release its second quarter financial results on Tuesday, October 28, 2008 before the market opens.

2008-10-16 09:00:42

Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing the next generation of proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the 2008 Boston Biotech R&D Conference, at 9:00 a.m.

2008-08-28 09:01:23

Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing the next generation of proprietary targeted medicines for cancer treatment, today announced that its collaborator Genentech, Inc.


Word of the Day
shotta
  • An armed gangster.
The word 'shotta' is an alteration of 'shooter'.